EverQuote (EVER)
(Delayed Data from NSDQ)
$20.04 USD
+0.39 (1.98%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $20.07 +0.03 (0.15%) 7:58 PM ET
1-Strong Buy of 5 1
D Value A Growth A Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$20.04 USD
+0.39 (1.98%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $20.07 +0.03 (0.15%) 7:58 PM ET
1-Strong Buy of 5 1
D Value A Growth A Momentum B VGM
Zacks News
Here's Why Radian Group (RDN) Stock is an Attractive Bet
by Zacks Equity Research
Radian Group (RDN) remains poised for growth on improved mortgages insurance and lower levels of paid claims.
EverQuote, Inc. (EVER) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
EverQuote, Inc. (EVER) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
EverQuote, Inc. (EVER) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in EverQuote, Inc. (EVER).
5 Stocks That Pushed Russell 2000 ETF Higher
by Sweta Killa
Inside the best performing stocks of the Russell 2000 ETF.
Willis Towers (WLTW) Gains on Revenue Growth & Acquisitions
by Zacks Equity Research
Willis Towers Watson (WLTW) is poised to gain on increase in commissions and fees and strategic acquisitions.
Assurant (AIZ) Scales 52-Week High: Will the Rally Continue?
by Zacks Equity Research
Assurant (AIZ) reaches 52-week high, driven by strong-third-quarter results.
Arthur J. Gallagher (AJG) Unit Acquires Horseshoe Insurance
by Zacks Equity Research
Arthur J. Gallagher (AJG) unit completes the buyout of Horseshoe Insurance to expand in the ILS market.
Strategic Plans, Solid Capital Position Aid Assurant (AIZ)
by Zacks Equity Research
Assurant (AIZ) is poised to grow given its strategic initiatives and effective capital deployment.
EverQuote, Inc. (EVER) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
EverQuote, Inc. (EVER) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Assurant (AIZ) Hikes Dividend to Boost Shareholder Value
by Zacks Equity Research
Assurant (AIZ) maintains its track record of dividend hikes which reflects operational efficiency and a strong capital position.
EverQuote, Inc. (EVER) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
EverQuote, Inc. (EVER) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
EverQuote, Inc. (EVER) Is Up 15.45% in One Week: What You Should Know
by Zacks Equity Research
Does EverQuote, Inc. (EVER) have what it takes to be a top stock pick for momentum investors? Let's find out.
Top Ranked Momentum Stocks to Buy for November 8th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, November 8th
Company News For Nov 6, 2019
by Zacks Equity Research
Companies In The News Are: CPE, EVER, MYGN, AAN
EverQuote, Inc. (EVER) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
EverQuote, Inc. (EVER) delivered earnings and revenue surprises of 250.00% and 15.12%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: EverQuote, Inc. (EVER) Q3 Earnings Expected to Decline
by Zacks Equity Research
EverQuote, Inc. (EVER) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
5 Insurers Outperforming S&P 500 Year to Date
by Tanuka De
We zero in on five insurance stocks, which managed to outperform the Zacks S&P 500 composite and insurance industry year to date.
EverQuote, Inc. (EVER) Upgraded to Strong Buy: Here's Why
by Zacks Equity Research
EverQuote, Inc. (EVER) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
EverQuote, Inc. (EVER) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
EverQuote, Inc. (EVER) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
EverQuote, Inc. (EVER) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in EverQuote, Inc. (EVER).
EverQuote, Inc. (EVER) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
EverQuote, Inc. (EVER) delivered earnings and revenue surprises of 46.67% and 9.53%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Will EverQuote, Inc. (EVER) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
EverQuote, Inc. (EVER) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is EverBank Financial a Great Stock for Value Investors?
by Zacks Equity Research
Is EverBank Financial a great pick from the value investor's perspective right now? Read on to know more.